|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| (11) | Number of the document | 3495380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18182274.3 |
| Date of filing the European patent application | 2013-12-10 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-30 |
| (46) | Date of publication of the claims translation | 2022-06-27 |
| (30) | Number | Date | Country code |
| 201261735823 P | 2012-12-11 | US |
| (72) |
AGORAM, Balaji , GB
ANTONSSON, Madeleine , SE
BEDNAREK, Maria, A , GB
BURMEISTER, Nicole , GB
BENTHEM, Lambertus , SE
FAIRMAN, David , GB
FRITSCH-FREDIN, Maria , SE
JACKSON, Ronald Henry , GB
LOFMARK, Rasmus Jansson , SE
METCALFE, Jaqueline , GB
|
| (73) |
MedImmune Limited ,
Milstein Building
Granta Park, Cambridge
Cambridgeshire CB21 6GH,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ko-agonistai gliukagonas ir GLP-1, skirti nutukimo gydymui |
| GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY |
| Payment date | Validity (years) | Amount | |
| 2024-10-25 | 12 | 289.00 EUR |
| 2025-12-10 |